K-134, a phosphodiesterase 3 inhibitor, reduces vascular inflammation and hypoxia, and prevents rupture of experimental abdominal aortic aneurysms by Naoki Unno, MD, Hiroki Tanaka, MD, PhD, Tatsuro Yata, MD, PhD, Takafumi Kayama, MD, Yuta Yamanaka, MD, Hajime Tsuyuki, MD, Masaki Sano, MD, PhD, Kazunori Inuzuka, MD, PhD, Ena Naruse, CVT, Hiroya Takeuchi, MD, PhD

Get full text